Faculty Profile

Prof. Anjana Munshi
Dean School of Health Sciences and HOD
Department of Human Genetics and Molecular Medicine
School of Health Sciences
Central University of Punjab
Bathinda- 151001
Email Id: anjanadurani@yahoo.co.in 
Mobile: 9848842776

 
Research/Teaching Experience : 20 Years

ACADEMIC HONOURS
  1. Qualified NET conducted by UGC and CSIR, New Delhi.
  2. Awarded SRF by CSIR.
  3. Qualified NET (Genetics) conducted by Agricultural Scientists Recruitment Board, New Delhi.     
  4. Awarded Research Associateship by CSIR.
  5. Life Member Indian Society of Human genetics.
  6. Life Member Third World Organization for Women in Science.
  7. Recognized Ph.D. guide (Genetics) of the Dr. NTR University of Health Sciences, Vijayawada and Nizam’s Institute of Medical Sciences, Hyderabad.
  8. The review entitled “Histone Modifications Dictate Specific Biological Readouts” was awarded as JGG Excellent Review Paper with the bonus of RMB 3000 and a medal.
  9. EC member, Indian Society of Human Genetics(2015)
  10. Life member, All India Congress of Cytology and Genetics
  11. Life member, Indian Science Congress
  12. Member IQAC , Central University of Punjab
  13. Member World Stroke Rights Bill.
  14. Member EC and AC, Central University of Punjab.
  15. Certificate of Commendation for Research Publications with CIF more than 15 in the year 2014-2015.
Research Projects :
  • “Genetic Polymorphism associated with stroke in a South Indian Population” funded by ICMR in collaboration with CCMB and NIMS Hyderabad (2010-13; 37 Lakhs).
  • Training Programme “Prevention of Genetic Disorders and Birth Defects” (for PHC doctors of Andhra Pradesh) Organized by Rajiv Vidya Mission, SSA and Institute of Genetics and Hospital for Genetic Diseases (funded by Heath and Family Welfare, Govt. of Andhra Pradesh)Rs.18Lakhs.
  • “Amelioration of the Severity of β-thalassemia by Modifier Genes” (37Lakhs) funded by DBT, India.
  • “Insilico Screening of all functional genes in the human genome for the detection of deleterious SNPs for association studies” (ICMR) (39Lakhs)(2015-2018) is ongoing
  • “Identification of breast cancer gene alterations and effect on gene expression in breast cancer patients from the Malwa region of Punjab” The concept proposal has been accepted (ICMR).
Training Programme Grant :
  • Training Programme on Medical Genetics and Bioinformatics (DBT) (4Lakhs). 9th-23rd of March, 2016, Centre for Human Genetics and Molecular Medicine
RESEARCH AREAS :
  • Epidemiology and Genetics of Stroke and its Subtypes, Pharmacogenetic Studies in Stroke
  • Molecular basis of Cancer
  • Hemoglobinopathies and Modifier genes in thalassemia
Publications :104 (RESEARCH =74+ REVIEW ARTICLES=30)

Total impact points: 181.32 for research papers and 43.98 for review papers (Total Impact Factor-225.3)
Book chapters authored=19
Edited books:

  1. DNA sequencing: methods and applications
  2. Inherited Hemoglobin Disorders

Research Publications

  1. Quinoline-based protein–protein interaction inhibitors of LEDGF/p75 and HIV integrase: An in silico study". N. Chokkar*, S. Kalra*, M. Chauhan, A. Munshi and R. Kumar. (2018) Current topics in Medicinal Chemistry (accepted for publication) (I.F. - 3.35)
  2. Role of 2-Dimensional autocorrelation descriptors in predicting Antimalarial Activity of Artemisinin and its analogues: A QSAR study". S. Kalra, G. Joshi, R. Kumar, and A. Munshi. (2018). Current topics in Medicinal Chemistry. (I.F. - 3.35) DOI: 10.2174/1568026619666190119143838
  3. Genomic alterations associated with HER2+ breast cancer risk and clinical outcome in response to trastuzumab. Singla, H., Kaur, R. P., Shafi, G., Vashistha, R., Banipal, R. P. S., Kumar, V., & Munshi, A. (2018). Molecular biology reports, 1-9.[I.F.-1.8]
  4. Analysis of pro‐and anti‐inflammatory cytokine gene variants and serum cytokine levels as prognostic markers in breast cancer. Kaur, R. P., Vasudeva, K., Singla, H., Benipal, R. P. S., Khetarpal, P., & Munshi, A. (2018). Journal of cellular physiology. [I.F-4.0]
  5. PPInS: a repository of protein-protein interaction sitesbase. Kumar, V., Mahato, S., Munshi, A., & Kulharia, M. (2018). Scientific reports, 8(1), 12453. [Impact factor- 4.122]
  6. Association of elevated levels of C-reactive protein with breast cancer, breast cancer subtypes and poor outcome (2017). Kaur RP, Rubal, Banipal RPS, Vashistha R, Dhiman M and Munshi A. Current problems in cancer (Accepted; impact factor: 1.25)
  7. Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patients (2018). Kaur, RP, Shafi G, Benipal RPS, and Munshi A. Medical Oncology 35, 1-9. (Impact factor: 2.68)
  8. Serum Albumin Levels in Breast Cancer: Correlation with Overall Survival (2017) Kaur RP, Dhiman M, Vashitstha R, and Munshi A. Journal of Food and Nutritional Disorders (2017). (Impact Factor:0.6)
  9. Role of TLR4 (C1196T) and CD14 (C-260T) Polymorphisms in Development of Ischemic Stroke, Its Subtypes and Hemorrhagic Stroke (2017) Das S, Kaul , Jyothy A and Munshi A. Journal of Molecular Neuroscience 63: 300–307(Impact factor 2.229).
  10. Apert's syndrome: study by whole exome sequencing. Munshi A , Khetarpal P, Das S, Rao V, Valecha M, Bansal M, Kumar R. Genes & Diseases (Accepted for Publication)
  11. Pyrimidine Containing Epidermal Growth Factor Receptor Kinase inhibitors: Synthesis and Biological Evaluation. Joshi J, Nayar H, Kalra S, Sharma P, Munshi A, Singh A and Kumar R. Chemical Biology & Drug Design (published online) doi: 10.1111/cbdd.13027 (Impact Factor 2.8)
  12. Association of APOE (E2, E3 and E4) gene variants and lipid levels in ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population (2016) Das S, Kaul S, Jyothy A, Munshi A. Neuroscience Letters 628:136-41(2.107).
  13. Mutational analysis in Gaucher disease: implications in Genetic counseling and Management (2016) Panigrahia I, Kalra J, Goyada P, Khetarpal P and Munshi A Journal of Genetic Disorders & Genetic Reports 5(1):1-5 (Impact factor: 0.7) .
  14. MTHFR Gene (C677T) Polymorphism in Ischemic Stroke, its Subtypes and Hemorrhagic Stroke in a South Indian Population (2015) Das S, Roy S, Kaul S Jyothy A and Munshi A . Acta Medica International 2(2):28-33. (Impact factor: 1.97).
  15. Association of BCL11A Genetic Variant (rs11886868) with severity in β-Thalassemia Major and Sickle Cell Anemia (2015) Dadheech S, Madhulatha D, Jain S, Joseph, J , Jyothy A ,and Munshi A. Indian Journal of Medical Research (accepted for publication) (Impact factor: 1.396).
  16. Computer aided identification of sodium channel blockers in the clinical treatment of epilepsy using molecular docking tools (2015) Shaheen S , Jyothy A,  Hinore JS, Girdhar A, Bandaru S, Sumithnath TG, Nayarisseri A and Munshi A. Bioinformation 11(3) : 131-135.
  17. Genetic determinants in ischaemic stroke subtypes: Seven year findings and a review (2015) Munshi A, Das S, Kaul S. Gene 555(2):250-259. (Impact factor: 2.138).
  18. Association of serum trace elements and minerals with genetic generalized epilepsy and idiopathic intractable epilepsy (2014). Prasad DK, Shaheen U, Satyanarayana U, Surya Prabha T, Jyothy A and Munshi A. Neurochem Res. 39(12):2370-6.(Impact factor:2.593).
  19. Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease Jharna P ,Sukanya B,  Ajit Kumar , Siddapuram SV, Jyothy A and  Munshi A. Indian J Gastroenterol. 33(6):524–529.
  20. Interleukin 1ß (+3954, -511 and -31) polymorphism in chronic periodontitis patients from North India (2014) Amirisetty R,  Patel R P,  Das S,  Saraf J,   Jyothy A,  Munshi  A. Acta odontologica scandinavica 73(5):343-7. (Impact factor: 1.03).
  21. Association of -1382A>G CCL11 gene variant with ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian Population (2014) Roy S, Das S,  Sharma V, Kaul S, Jyothy A, Munshi A. Neurology India 62(4):387-392 (Impact factor: 1.044).
  22. E-selectin gene (S128R) polymorphism in hemorrhagic stroke: comparison with ischemic stroke  (2014) Das S, Roy S, Sharma V, Kaul S, Jyothy A, Munshi A. Neuroscience letters 3 (581):125-128 (Impact factor: 2.169)
  23. Association of GABRA6 1519 T>C (rs3219151) and Synapsin II (rs37733634) gene polymorphisms in the development of IdiopathicGeneralized Epilepsy (2014)Prasad DKV, ShaheenaU ,Satyanarayana U,  SuryaPrabha  T, Jyothy A, Munshi A. Epilepsy Research 39(12):2370-2376  (Impact factor: 2.316).
  24. Association of ACE gene I/D polymorphism and ACE levels with hemorrhagic stroke:comparison with ischemic stroke (2014) Das S, Roy S, Sharma V, Kaul S,  Jyothy A, Munshi A. Neurological Sciences 36(1):137-42. (Impact factor: 1.447).
  25. CRP Gene (1059G>C) Polymorphism and its Plasma Levels in Ischemic Stroke and Hemorrhagic Stroke in a South Indian Population (2014) Das S, Roy S, Kaul S, Jyothy A, Munshi A. Inflammation  37(5):1683-8 (Impact factor: 2.208).
  26. Association of E-selectin Gene Polymorphism (S128R) with Ischemic Stroke and Stroke Subtypes (2014) Roy S, Das S, Danaboina R, Sharma V, Kaul S, Jyothy A and Munshi A. Inflammation 37(2) 599-603. (Impact factor: 2.208).
  27. Association of the genetic variants of insulin receptor substrate 3 1 (IRS1) with type 2 diabetes mellitus in a Saudi population. Alharbi K K,  Khan  I A, Munshi A Alharbi  F K, Al-Sheikh  Y, Alnbaheen M S (2014) Endocrine DOI 10.1007/s12020-014-0177-2 (Impact factor: 3.878).
  28. Association of Xmn1-158 γ G variant with severity and HbF levelsin β-Thalassemia major and Sickle cell anaemia (2014) Dadheech S, Jain S, Madhulatha D, Sharma V, James Joseph J, Jyothy A, Munshi A. Molecular Biology Reports 41(5):3331-7 (Impact factor: 2.024).
  29. Significance of MDR1 gene polymorphism C3435T in predicting drug response in
    epilepsy (2014) Shaheen U,Prasad D K V , Sharma V, Suryaprabha T, AhujaY R, Jyothy A ,  Munshi A. Epilepsy Research108: 251-256 (Impact factor: 2.316) .
  30. Three most common non-synonymous UGT1A6*2 polymorphisms (Thr181Ala, Arg184Ser and Ser7Ala) and therapeutic response to deferiprone in β-Thalassemia Major patients. Sneha D,Rao AV, Uzma, Hussien MD, Jain S,  A Jyothy, Munshi A.   (2013) Gene. 531(2): 301 (Impact factor: 2.138).
  31. ABCA1 C69T gene polymorphism and risk of type 2 diabetes mellitus in a Saudi population (2013) Alharbi K K , Khan I A,  , Al-daghri NM , Munshi A , Vandana sharma , Mohammed A K  , Wani K A , Al-sheikh1 Y A A ,  Salem al-Nbaheen M, Ansari2 M Gand and Rabbani S.  J. Biosci. 38(5) : 893–897. (Impact factor: 2.064).
  32. Association of ALOX5AP1 SG13S114T/A Variant with Ischemic Stroke Stroke subtypes and Aspirin resistance. Sharma V,  Dadheech S, Kaul S, Jyothy A, Munshi A. (2013) J Neurol Sci 331(1-2):108-13 (Impact factor: 2.535).
  33. Association of serum uric acid level with ischemic stroke, stroke subtypes and clinical outcome (2013) Koppula R, Kaul S, Rao AV, Jyothy A, Munshi A. Neurology Asia 18(4) : 349-353 (Impact factor: 0.162).
  34. An association of COX-2 rs20417 with Aspirin resistance (2013) Sharma V,  Kaul S, Al-Hazzanid A, Alshatwi AA, Jyothy A, Munshi A. Thrombosis and Thrombolysis 35(1): 95-9. (Impact factor: 2.169).
  35. Serum albumin level in ischemic stroke and its subtypes: correlation with clinical outcome (2013) SaiBabu M, Kaul S, Dadheech S, Rajeshwar K,Jyothy A, and Munshi A. Nutrition 29(6):872-875 (Impact factor: 2.99).
  36. Variants of DHFR, MTHsFD1 and MTHFR genes: Relation to CNS malformations (2013) Munshi A, Prasoona R, Sunitha T, Jyothy A. Indian Journal of Obstetrics and Gynecology. 64 (1):24-25.
  37. A novel LMNA mutation in two South Indian siblings with Hutchinson-Gilford progeria syndrome (2013) Munshi A, Satyanarayana U, Babu MS, Vasundhara A, Harischandra YV,  Krishna A, Kumari JS andJyothy A International Journal of Genetics 5(1):116-120 (Impact factor: 4.220).
  38. A Rare Occurrence of Concordant Neural Tube Defects in Monozygotic Twins of an Epileptic Woman (2012) Sunitha T, Rebekah Prasoona K, Munshi A, Sujatha M, Surya Prabha T, Jyothy A. Neurology India 60(4):428-429 (Impact factor: 1.232)
  39. Genetic variation in MDR1, LPL and eNOS genes and the response to atorvastatin treatment in ischemic stroke (2012) Munshi A. Human Genetics 131(11): 1775-1781 (Impact factor: 4.824).
  40. Association of SNP41, SNP56 and a novel SNP in PDE4D with stroke and its subtypes (2012) Munshi A, Roy S, Thangaraj K, Kaul S, SaiBabu M, Jyothy A. Gene; 10;506(1) (Impact factor: 2.535).
  41. Pharmacogenoinformatics: modeling of p-glycoprotein and novel approach of in silico drug designing based on genetic variation of mdr1 gene involved in statin resistance (2012) SaiBabu M, Venkateswara Rao A, LakshmanTeja G, Kaul S, JyothyA, Munshi A. International journal of drug discovery 4(1) 145-152.
  42. Association of LPL gene variant and LDL, HDL, VLDL cholesterol and triglyceride levels with ischemic stroke and its subtypes (2012) Munshi A, SaiBabu M, Kaul S, Rajeshwar K, Balakrishna N, Jyothy A. Journal of Neurological Sciences 318 (1-2) 51-4 (Impact factor: 2.413).
  43. Cytokine gene polymorphisms in the susceptibility of Acute Coronary Syndrome (2012) SrikanthBabu BMV, Pulla Reddy B, SaiPriya VH, Munshi A, Rani HS, Latha GS, Rao VD and Jyothy A. Genetic Testing and Molecular Biomarker16(5) 359-65 (Impact factor: 1.464).
  44. Artemisia absinthium (AA) a novel potential complementary and alternative medicine for breast cancer (2012) Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, Alshatwi AA, Jyothi A, Munshi A. Molecular Biology Reports 39(7) 7373-9 (Impact factor: 2.92).
  45. Association of Genetic Variants of Fibrinolytic System with Stroke and Stroke Subtypes (2012) SaiBabu M,  Kaul S, Al-Hazzani A, Shafi G, Rajeshwar  K, Roy S, Alladi S, Balakrishna N, Jyothy A and Munshi A.Gene 495: 76-80(Impact factor: 2.138)
  46. Association of C3435T Multi drug resistance gene-1 polymorphism with aspirin resistance in ischemic stroke and its subtypes (2012) Sharma V, Kaul S,  Al-Hazzani A, Rajeshwar K ,  SaiBabu M, Dadheech S, Jyothy A, Munshi A. Journal of the Neurological Sciences 315(1-2) 72-6 (Impact factor: 2.535).
  47. C-Reactive protein and nitric oxide levels in ischemic stroke and its subtypes: Correlation with clinical outcome (2012) Rajeshwar K, Kaul S, Al-Hazzani A, Babu MS, Balakrishna N, Sharma V, Jyothy A and Munshi A. Inflammation 35(3) 978-84(Impact factor: 2.208).
  48. Association of 1347 G/Acytochrome P450 4F2 (CYP4F2) Gene VariantwithHypertension and Stroke (2012) Munshi A, Sharma V, Kaul  S, Al-Hazzani A, Alshatwi AA,Shafi G, Rajeshwar K, SaiBabu M and JyothyA. Molecular Biology Reports 39(2):1677-1682(Impact factor: 2.92).
  49. Apoptosis-Mediated Proliferation Inhibition of Human Breast Cancer Cells by Lemon Citrus Extract (2011) Alshatwi AA, Shafi G, Hasan TN, Al-Hazzani A, Alsaif MA, Alfawaz MA, Lei KY and Munshi A. Asia-Pacific Journal of Clinical Oncology 12(6) 1555-1559 (Impact factor: 1.542).
  50. Comparative analysis of hemagglutinin of 2009 H1N1 influenza A pandemic indicates its evolution to 1918 H1N1 pandemic (2011) Masoodi TA, Shaik NA, Shafi G, Munshi A, Ahamed AK and Masoodi ZA. Gene 491(2) 200-204(Impact factor: 2.138).
  51. Modulatory effect of Curcumin in Pentylenetetrazol induced Kindling in rats (2011) Sharma V, Nehru B, Hota B, Sharma S and Munshi A. Journal of PharmacyResearch14 (9)2891-2893(Impact factor: 2.89).
  52. Methanolic Extract of Nigella sativa Seed Inhibits SiHa Human Cervical Cancer Cell Proliferation through Apoptosis (2011) Al-Hazzani AA, Hasan TN, Shafi G, Alshatwi A A,Alsaif MA, Munshi A, Alfawaz MA and Lei KY. Natural Product Communications 61-63 (Impact factor: 0.906).
  53. Association of Vitamin D receptor gene polymorphisms with BMD and their effect on 1-2-5-dihydroxy Vitamin D3 levels in pre and post-menopausal South Indian women from Andhra Pradesh (2011) Yasovanthi J, Pulla Reddy B, Karunakar KV, Munshi A,  Narasimulu G and Jyothy A. Clinica Chimica Acta 412 541–544(Impact factor: 2.824).
  54. Lack of association of G779A ZHX-2 gene variant with HbF levels in β- thalassemia major(2011) Munshi A, Dadheech S, Jain S, Joseph J, Al-HazzaniA,Alshatwi AA, SaiBabu M, Rajeshwar K and Jyothy A. European Journal of Haematology 86 502-506(Impact factor: 2.066).
  55. Response to Kountouras (2011) Munshi A and Al-Hazzani A.European Journal of Neurology18e77 (Impact factor: 4.055).
  56. Association of Tumor Necrosis Factor-α and Matrix Metalloproteinase-3 gene variants with Stroke (2011) Munshi A, Rajeshwar K, Kaul S, Al-Hazzani A, Alshatwi AA, Shafi G, Balakrishna N and Jyothy A. European Journal of Neurology18 1053–1059 (Impact factor: 4.055).
  57. Protective effect of curcumin  on behavioral impairment induced by Pentylenetetrazol in Rats (2011) Sharma V, Nehru B, Munshi A, Khanna P and SharmaS. Journal of Pharmacy Research 4(1) 11-14(Impact factor: 2.89).
  58. In-Silico Analysis of Polymerase Basic Protein 2 in Different Strains of Influenza A Virus (2010) Masoodi TA, Shafi G and Munshi A. Journal of Computational Intelligence in Bioinformatics 3(2) 211-220.
  59. Interleukin-10-1082 Promoter Polymorphism and ischemic Stroke Risk in a South Indian Population (2010) Munshi A, Rajeshwar K, Kaul S, SaiBabu M, Anila AN, Alladi S and Jyothy A. Cytokine 52 221–224(Impact factor: 2.664).
  60. Estrogen receptor α genetic variants and the risk of stroke in a South Indian population from Andhra Pradesh (2010)Munshi A, Sharma V, Kaul S,Al-Hazzani A,Alshatwi A A, Raj Manohar V, Rajeshwar K, SaiBabu M and JyothyA.Clinica Chimica Acta 411 1817–1821(Impact factor: 2.824).
  61. Angiotensin converting enzyme gene variant and its levels are risk factorsformyocardialinfarction in a South Indian population (2010) Reddy P, Babu S, Katunakar V, Yashovanti J, Munshi A, Kumar S, Sharath A and Jyothy A. Singapore Medical  Journal 51(7) 576-581(Impact factor: 0.597).
  62. Serum Zn depletion in stroke (2010) Munshi A, SaiBabu M, Gowhar S, Rajeshwar K, Kaul S and Jyothy A. Methods Find Exp Clin Pharmacol 32(6) 433-436(Impact factor: 0.774).
  63. Association of the -344C/T Aldosterone Synthase (CYP11B2) Gene Variant with Hypertension and Stroke (2010) Munshi A, Sharma V, Kaul S,Rajeshwar K,  SaiBabu M, Shafi G, Balakrishna N, Alladi S and Jyothy A.Journal of the Neurological Sciences 296 34–38(Impact factor: 2.535).
  64. VNTR polymorphism in intron 4 of the eNOS gene and the risk of ischemic stroke in a South Indian population (2010) Munshi A,Rajeshwar A, Kaul S, Chandana E, Gowhar Shafi, Anila A, Balakrishna N, Alladi S and Jyothy A. Brain Research Bulletin 82 247-250(Impact factor: 2.718).
  65. Antioxidant and Neuroprotective Potentials of Curcumin against oxidative insult induced by Pentylenetetrazole in Epileptic rats (2010) Sharma V, Nehru B, Munshi A and Jyothy A. Methods and Findings in Experimental and Clinical Pharmacology 32(4) 227-232(Impact factor: 0.774).
  66. The M235T polymorphism of the angiotensinogen gene in South Indian patients of hypertrophic cardiomyopathy (2010) Manohar Rao PP, Munshi A, Mullapudi R, Kumar PS, Sharath A, Krishna GA and  Sadhnani M.J Renin Angiotensin Aldosterone Syst 12(3)238-242(Impact factor: 2.40).
  67. Association of estrogen receptor α gene polymorphisms with BMD and their effect on estradiol levels in pre-and postmenopausal women in a South Indian population from Andhra Pradesh (2010) Yasovanthi J, Pulla Reddy B, Karunakar KV, Munshi A, Venkateswari A, Narasimulu G and Jyothy A. Clinica Chimica Acta 411 597–600(Impact factor: 2.824).
  68. Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella Sativa (2009) Shafi G, Munshi A, Hasan TN, Alshatwi A, Jyothy A and Lei DKY. Cancer Cell Internaional 9 29(Impact factor: 2.770).
  69. Phosphodiesterase 4D (PDE4D) gene variants and the risk of ischemic stroke in a South Indian population (2009) Munshi A, SaiBabu M, Kaul S, Shafi G, Anila A N, Alladi S and JyothyA. Journal of the Neurological Sciences 285 142-145(Impact factor: 2.243).
  70. Prothrombin gene  G20210A mutation is not a risk factor for ischemic stroke in a South Indian Hyderabadi population (2009) Munshi A, Kaul S, Aliya N, Shafi G, Alladi S and Jyothy A. Thrombosis Research124  245–247(Impact factor: 2.447).
  71. Inherited hemoglobin disorders in Andhra Pradesh, India: A population study (2009) Munshi A, Anandraj MPJS, Joseph J, Shafi G, Anila AN andJyothy A. Clinica Chimica Acta400 117-119(Impact factor: 2.66).
  72. Angiotensin –converting enzyme insertion /deletion polymorphism and the risk of ischemic stroke in a South Indian population (2008) Munshi A, Sultana S, Kaul S, Pulla Reddy B, Alladi S and Jyothy A. Journal of the Neurological Sciences 272 132-135(Impact factor: 2.535)
  73. Cytogenetic studies on primary trisomics of Plantagolanceolata L (1995) Munshi A, Sareen S, Langer A and Kaul AK. National Academy of Sciences India B61 (4) 339-346. (Impact factor: 0.396)
  74. A novel aneuploid in Plantagolanceolata L (1994) Munshi A, Langer A and Kaul AK. The Nucleus 37 (1, 2) 23-24.
  75. Genetic diversity among Plantagos XXV. Isolation of an autotriploid from a cross between disomic (2nd-12) and trisomic (2n=12+1) plants of P. lanceolata L (1991) Munshi A, Langer A and Kaul AK. The Nucleus 35 (2, 3) 97-100.
  76. Studies on primary trisomics of Plantagolanceolata L Genetic diversity among Plantagos XIX (1990) Sareen S, Munshi A, Kaul AK and Langer A. Cytologia 55 601-608(Impact factor: 0.205).
  77. An interchange trisomic in Plantagolanceolata L Genetic diversity among Plantagos X (1989) Sareen S, Munshi A, Kaul A K and Langer A. Cytologia 55 357-361(Impact factor: 0.205).

REVIEW ARTICLES PUBLISHED  

  1. Role of p53 Gene in Breast Cancer: Focus on Mutation Spectrum and Therapeutic strategies. Kaur, R. P., Vasudeva, K., Kumar, R., & Munshi, A. (2018). Current pharmaceutical design. [I.F-2.7]
  2. Genetics of platelet traits in ischemic stroke:Focus on mean platelet International journal of neuroscience. Vasudeva, K. & Munshi, A. International journal of neuroscience [I.F-1.9] (Accepted for publication)
  3. BRCA1 mutation spectrum, functions and therapeutic strategies: The story so far. Sharma, B., Kaur, R. P., Raut, S., & Munshi, A. (2018). Current Problems in Cancer. DOI: 10.1016/j.currproblcancer.2018.01.001. (Impact factor: 1.2)
  4. A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors. Shailani, A., Kaur, R. P., & Munshi, A. (2018). Medical Oncology, 35(3), 18. (impact factor: 2.6)
  5. Pharmacological and molecular approaches for the treatment of β-hemoglobin disorders. Lohani M, Bhargava N, Munshi A and Ramalingam S (2017). Journal of Cellular Physiology. DOI1002/jcp.26292 (Impact factor: 4.8).
  6. Genetic signatures in ischemic stroke: Focus on aspirin resistance. K, Chaurasia P, Singh S and Munshi A (2017) CNS Neurol Disord Drug Targets doi: 10.2174/1871527316666171002115633(Impact factor: 2.61).
  7. Recent Advances in HER2 Positive Breast Cancer Epigenetics: Susceptibility and Therapeutic Strategies. Singla H., Ludhiadch A., Kaur R., Chander H., Kumar V., Munshi A. Eur. J. Med. Chem (accepted for publication) (Impact factor: 4.5).
  8. Research advances in Apert syndrome. Das S and Munshi A. Journal of Oral Biology and Craniofacial Research DOI: 10.1016/j.jobcr.2017.05.006.
  9. Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-Therapy. Singla H, Kalra S, Kheterpal P, Kumar V, Munshi A (2017) Curr Cancer Drug Targets. Volume 17, Number 4, Mpp. 17(4): 344-356(13) (Impact factor: 3.707).
  10. Primordial dwarfism: overview of clinical and genetic aspects. Khetarpal P, Das S, Panigrahi I, Munshi A (2016) Mol Genet Genomics 291(1):1-15. (Impact factor: 2.728).
  11. Non-Coding RNAs: A Dynamic and Complex Network of Gene Regulation. Munshi A , Mohan V and Ahuja YR (2016) Journal of Pharmacogenomics & Pharmacoproteomics 7:1:2-11.
  12. Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-Therapy. Singla H, Kalra S, Kheterpal P, Kumar V, Munshi A (2016) Curr Cancer Drug Targets. 2016 Dec [Epub ahead of print] (Impact factor: 3.707).
  13. Precision medicine in stroke: an ideal model for stroke treatment. Munshi A and Sharma V (2016) Precision medicine 1(1):10-12.
  14. Association between PDE4D gene and ischemic stroke: Recent Advancements (2015) Das S, Roy S and Munshi A. The International Journal of Neuroscience May 23:1-17. (Impact factor: 1.521).
  15. Genetics of idiopathic generalized epilepsy: An overview (2013) Prasad DKV, Satyanarayana U, Munshi A. Neurology India 61(6):572-577 (Impact factor: 1.232).
  16. Genetic Signatures in the Treatment of Stroke (2015) Munshi A, Sharma V. Current Pharmaceutical Design 21(3):343-54 (Impact factor: 3.452).
  17. Genetic Modifiers of Β-Thalassemia-Review. (2013) Jyothy A, Munshi A. AP Academy of Sciences: Special Issue Women in Science 15(1): 23-27.
  18. Genetics of Non-alcoholic Fatty Liver Disease: an Overview (2013) Puppala J, Siddapuram SP, Jyothy A and Munshi A. Journal of Genetics and Genomics 40(1): 15-22 (Impact factor: 3.585).
  19. Pharmacogenetics in Epilepsy Treatment-A Predictor of Therapeutic Efficacy 2012) Surya Prabha T, Sharma V, Sharma S and Munshi A. Journal of Pharmacy Research 5(2):727-736(Impact factor: 2.89).
  20. Genes associated with Alzheimers Disease (2010) Munshi A and Ahuja YR.Neurology Asia 15(2):109-118 (Impact factor: 0.162).
  21. Stroke Genetics-An Overview (2010) Munshi A and Kaul S. Neurology India 58(2):181-187 (Impact factor: 1.232).
  22. Micro-RNA signatures in neurological disorders (2010) Shafi G, Aliya, N and Munshi A. Canadian Journal of Neurological Sciences 37 (2):177-185(Impact factor: 1.525).
  23. Environmental modifications of epigenetics and its consequences. (2009) Ahuja YR, Munshi A and JahanP. Proc AP Akademi of Sciences 13(1-4):87-92.
  24. Histone modifications dictate specific biological readouts (2009) Munshi A, Shafi G, Aliya N and JyothyA.Journal of Genetics & Genomics 36: 1-14(Impact factor: 3.585).
  25. Nutrigenomics-looking to DNA for Nutrition advice (2008) Munshi A and Shanti D. Indian Journal of Biotechnology 7:32-40(Impact factor: 0.386).
  26. Stroke genetics-Focus on PDE4D gene (2008) Munshi A and KaulS.International Journal of Stroke 3: 188-192(Impact factor: 3.833).
  27. Genomic imprinting- the story of other half and the conflicts of silencing (2007) Munshi A and Shanti D.Journal of Genetics and Genomics 34(2): 93-103(Impact factor: 3.585).
  28. Stem cells in toxicology (2006) Jahan P, Munshi A and Ahuja YR.Perspectives in Cytology and Genetics12: 79-81(Impact factor 0.379).
  29. The Evil Prions (2005) Munshi A. Advanced Biotech 21-25.
  30. Regenerative medicine (2004) Jahan P, Munshi A and Ahuja YR.Perspectives in Cytology and Genetics11: 173-179(Impact factor 0.379).

BOOK CHAPTERS CONTRIBUTED

  1. Munshi A and Das S. (2017) Genetic understanding of stroke treatment:
    potential role for phosphodiesterase inhibitors “Phosphodiesterases-CNS
    Functions and Disease Adv Neurobiol”. 2282-8, Chapter 17(Springer)pp445-461.
  2. Munshi A and Sharma V. (2017) Circulating tumor cells and circulating tumor DNA. “Precision medicine precision medicine: prediction, prevention with personalization” .Cat. No.: k29688 Chapter 10, CRC press Taylor and Francis). Accepted for publication.
  3. Munshi A and Sharma V. (2017) Precision medicine in stroke and other neurological disorders“Precision medicine precision medicine: prediction, prevention with personalization” .Cat. No.: k29688 Chapter 2 CRC press Taylor and Francis). Accepted for publication.
  4. Munshi A, Sharma V. (2016). Safety and ethics in biotechnology and bio-engineering: what to follow and what not. “OMICS TECHNOLOGIES AND BIO-ENGINEERING: towards improving quality of life, Chapter 32 (Academic Press imprint: Elsevier). Accepted for publication.
  5. Munshi A,Sharma V. (2016). Omics approaches in molecular farming and engineering for edible vaccines “OMICS TECHNOLOGIES AND BIO-ENGINEERING: towards improving quality of life, Chapter 42 (Academic Press imprint: Elsevier). Accepted for publication.
  6. Munshi A and Sharma V and Sharma S. (2016) Lessons learned from cohort studies, and hospital based studies and their implications in precision medicine “Progress and Challenges in Precision Medicine” Chapter 12 (Taylor and Francis) Accepted for publication
  7. Munshi A, Ahuja YR, Bahadur B. (2015) Epigenetic Mechanisms in Plants: An Overview “Plant Biology and Biotechnology” ISBN 978-81-322-2282-8,Chapter 12(Springer)pp265-278
  8. Hasan TN, Shafi G, Grace L, Tegner J, and Munshi A. (2015) DNA Methylation: An Epigenetic Marker of Breast Cancer Influenced by Nutrients Acting as an Environmental Factor. “Noninvasive Molecular Markers in Gynecologic Cancers”. ISBN 9781466569386 - CAT# K16436, Chapter 6(CRC Press, Taylor and Francis Group) pp 187-202
  9. Munshi A, Dadeech S, Babu S and Khetarpal P. (2015). Modifiers of γ-globin gene expression and treatment of β-thalassemia. “Inherited Hemoglobin Disorders”, ISBN 978-953-51-2198-5, Chapter 7(Intech Publishers, Europe) pp 103-136.
  10. Munshi A. (2014). Nutrigenomics: Gene based personalized nutrition advice. Woman and Food studies from the Indian sub-continent. (Lambert Academic Publishing). ISBN-13: 978-3848430710, Chapter 17, pp 120-135.
  11. Munshi A, Sharma V. (2014) Quality Control and Ethical Issues of Cancer Biomarker discovery. “Cancer Biomarkers: Non-invasive Early Diagnosis and Prognosis ISBN: 978-1-4665-8428-0, Chapter 1“(CRC press) pp 3-17.
  12. Munshi A, Sharma V. (2014) Insilico Disease Models of Breast Cancer. "Omics Approaches in Breast Cancer :Towards Next-Generation Diagnosis, Prognosis and Therapy” ISBN-13: 978-8132208426, Chapter 16 (Springer) pp 315-331
  13. Shafi G, Hasan TN, Syed NA, Paine A, Tegner J, Munshi A. (2014).Breast Cancer MicroRNAs: Clinical Biomarkers for the Diagnosis and Treatment Strategies. “Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy” ISBN-13: 978-8132208426, Chapter 8 (Springer) pp171-182.
  14. Sharma S, Munshi A. (2013). Omics approaches applications in Clinical Trials. Omics for Personalized Medicine (Springer) ISBN 978-81-322-1184-6 Chapter 7, pp 123-146.
  15. Munshi A, Ahuja YR. (2013). Ethical Considerations in Pharmacogenomics. Omics for Personalized Medicine (Springer). ISBN 978-81-322-1184-6 Chapter 8 pp 147-162.
  16. Munshi A, Crotti LB, Sharma V, Sharma S, Espinoza LA. (2013). Pharmacogenomics of Allergy and asthma. “Omics for Personalized Medicine” (Springer) ISBN 978-81-322-1184-6 Chapter 24, pp 529-560.
  17. Munshi A, Krupanidhi S, Ahuja YR. (2013) OMICS: Applications in Biomedical, Agricultural, and Environmental Sciences Epigenome. “Genomic response to environmental accentricities” (CRC Press, Taylor and Francis Group) ISBN: 978-1-4665-6281-3, Chapter 2, pp 44-63.
  18. Munshi A, Sharma V. Pharmacogenetics-A treatment strategy for alcoholism. (2012) Pharmacology (Intech Publishers) ISBN 978-953-51-0222-9, Chapter 12, pp 231-254.
  19. Sharma S, Munshi A. (2011). Pharmacogenomics in development of disease specific therapeutic strategies. “Omics-Biomedical Perspective and Applications” (Taylor and Francis publications) ISBN: 978-1-4398-5008-4. Chapter 17, pp 319–332.

Edited

  1. DNA Sequencing: Methods and Applications (Intech Publishers, Europe). ISBN 978-953-51-0564-0
  2. Inherited Hemoglobin Disorders (Intech Publishers, Europe) ISBN 978-953-51- 2198-5

Popular Articles

  • Lagging in Learning, Science Reporter, and Sept. 2005, 34-36.
  • Stroke- The brain attack, Science Reporter March 2006,24-27
  • Stroke Genetics, Stroke Talk Dialogue of Experts, Issue 2
Seminars / Workshop Organised
  1. Organized one day seminar on “Radiation Effects on Biology and Medicine” at the Institute of Genetics on 29th June, 2009, in collaboration with Indian Nuclear Society.
  2. Organized a 3 days conference on “Impact of Diseases and Social Issues Affecting Women and their Amelioration” at IICT auditorium on 12-14th December 2010 in collaboration with TWOWS (India).
  3. Organized a two days’ workshop on Fluorescent in situ Hybridization on 25th and 26th September, 2014at Centre for Human Genetics, Central University of Punjab, Bathinda, Punjab.

Presentation & Seminar Attended

  1. Studies on B. Chromosomes of Plantago Lanceolata L - 58th Annual Session of National Academy of Sciences, held at Jammu University, No. 5-7, 1988.
  2. Tetrasomy in Plangato Lanceolata L. - 4th All India Conference on Cytogenetics and Genetics and symposium on cytogenetics of Mulbery and Silk Worm, Bangalore.
  3. Regenerative Medicine – Perspectives in cytology and genetics 2002.
  4. Stem cells in toxicology – 12th All India Congress on Oncology and Genetics 2005, Mumbai.
  5. National Seminar on “Recent Advances in Biotechnology & Bioinformatics” July 2006 organized by SCBT, Hyderabad.

  6. National Seminar on “Women in Science & Technology” organized by TWOWS, Sept, 2006, IICT, Hyderabad.
  7. International symposium on “Chromosomes to Genome” organized by CCMB, Hyderabad from 3rd to 5th July 2007.
  8. National seminar on “Genome analysis perspective in the post genomic era and its relevance to society” organized by MGNIRSA, Hyderabad from 26th to 28th Oct.2007.
  9. AP Science Congress organized by AP Academy of Sciences and OU From14-16 November, 2008.
  10. Presented a poster on “Phoshodiesterase 4D genetic variants and risk for ischemic stroke in South Indian population” in Fourth National Congress of Indian Stroke Association. All India Stroke meeting organized by Nizam’s Institute of Medical Sciences, Hyderabad on 14&15th of March 2009.
  11. Presented a poster on “Association of Angiotensin converting enzyme insertion/deletion polymorphism and Prothrombin G20210A mutation with ischemic stroke in South Indian population” in Fourth National Congress of Indian Stroke Association. All India Stroke meeting organized by Nizam’s Institute of Medical Sciences, Hyderabad on 14&15th of March 2009.
  12. Presented a poster on “Polymorphism of Pro and anti-inflammatory genes and stroke risk in a South Indian population” in Science and technology: Its role in the changing global scenario, 2nd AP Science congress 2009, organized by Andhra Pradesh Akademi of Sciences and Sri venkateshwara University,Tirupati on 14th-16th of November 2009.
  13. “National seminar on Recent Advances in Development of Biomarkers for Cancer Prognosis and Treatment” organized by School of human research and genetic disorders& school of biotechnology, MahathmaGandhiu national institute of research and social action (MGNIRSA), Hyderabad on 22nd-24th of January 2010.
  14. Presented a poster on “Genetic variation at the Human Tissue-Type Plasminogen Activator (tPA) locus and the risk of Stroke”in 41st annual meeting of Environmental Mutagen society organized by EMS on October 23-27, 2010 at Omni Fort Worth, Texas, USA.
  15. A talk on “Nutrigenomics: Gene based personalized nutrition advice”  in National seminar cum workshop on Food and women organized by Sarojininaiducentre for women studies, Mahatma Gandhi national institute of research and social action (MGNIRSA), Hyderabad on 21st&22nd of January 2011.
  16. National Conference on “Nanobiotechnology: Emerging Trends and Applications in Microbiology” organized by  School of microbiology of  Mahatma Gandhi national institute of Research and social action (MGNIRSA), Hyderabad on 4th-6th February 2011. 
  17. “Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke” in International conference on genomics, genetic diseases and diagnosis and XXXVI annual conference of the Indian society of human genetics organized by Indian society of human genetics and Manipal life sciences centre, Manipal on 14th-16th of February 2011.
  18. “Dr. KJR Murthy memorial international seminar on Scientific and clinical aspects of tuberculosis” organized by Bhagwan Mahavir Memorial Trust, Hyderabad, Andhra Pradesh on 15th February 2012.
  19. “Genetic variation of Multi drug resistance gene-1 (C3435T) in stroke patients and Aspirin resistance” in national conference on “Biomarkers for diseases-prospects and challenges” organized by Centre for Biotechnology and bioinformatics (CBB) School of life sciences (SLS), Jawaharlal Nehru Institute of Advanced Studies (JNIAS), Hyderabad, Andhra Pradesh on 24-25th February, 2012. 
  20. Participated in one day seminar and work shop on “Caring for children with special needs-A holistic approach” organized by Institute of Genetics and Hospital for Genetic Diseases, OU, Nireekshana ACET, Hyderabad and Kimmy’s House, Colorado, USA on 27th February, 2012.
  21. Reoriantation programme on “Research methodology for Ph.D guides” conducted at Dr. NTR University of Health Sciences, Vijayawada, Andhra Pradesh from 9th to 13th July, 2012
  22. Delivered an invited talk on “Role of high throughput technologies in the management and control of the complex diseases”  in the International conference on Biotechnological innovations towards global development, organized by Department of Biotechnology &Bioinformatics, Bishop Heber College (Autonomous), Tiruchirapalli, Tamil Nadu  on 9th& 10thof January 2013.
  23. Oral presentation on “Estrogen receptor α genetic variants and the risk of stroke in pre- and postmenopausal women” in  International Conference on Women in Science and Technology in the Arab Countries on April 21-23, 2013 organized by  Kuwait Institute for Scientific Research (KISR), Kuwait
  24. Invited Talk on “Recent Advances in the understanding of Genetic Architecture of Complex Diseases Using High Throughput Technologies” in Nation Seminar on Emerging Trends Challenges and Innovative Approaches in Clinical Research in India organized by Bhagavan Mahavir Hospital on 27th-28th April at Hyderabad.
  25. Invited talk on “Genetic influences in the pathogenesis of multifactorial ischemic stroke and its subtypes” in NeuroUpdate organized by Calcutta National Medical College, Govt. of West Bengal & CSIR-Indian Institute of Chemical Biology on 28th -29th November, 2014.
  26. Attended “Recent Trends in Molecular Medicine” organized at Central University of Punjab, Bathinda, 2014.
  27. Invited talk on “PDE4D gene and ischemic stroke: Potential role for Phosphodiesterase inhibitors” New Frontiers in Diagnosis & Management of Genetic Diseases organized by Institute of Genetics & Hospital for Genetic Diseases, Osmania University, Hyderabad on 29th -30th of January, 2016.
  28. Chaired a session “Epigenetics and Developmental Genetics” in 41st meeting of Indian Society of Human Genetics, Annual meeting and International conference entitled celebrating Genetics–The Human Way. Organized by Vision Research Foundation, Chennai on 3rd-5th March, 2016.
  29. Presented two posters in 42nd meeting Indian Society of Human Genetics & International Symposium on trends in Human Genetic Research & Management, IISC,  Bangalore 2-4th  March, 2017.
Other Achievements :
  • Contributed in Establishing the Molecular Biology Division at Institute of Genetics and Hospital for Genetic Diseases, Osmania University.
  • Provided molecular diagnostic service and Counselling to  the referral cases (Total=5000 cases)  affected with Thalassemia, Sickle Cell anemia, Other structural variants of hemoglobin like E and D thal, Duchene Muscular Dystrophy ,Stroke, Progeria, Neural Tube Defects using various molecular techniques.
  • Established Centre for Human Genetics at Central University of Punjab.
Collaboration :
  • Institute of Genetics and Hospital for Genetic diseases, Osmania University, Hyderabad.
  • Centre for Cellular and Molecular Biology, Hyderabad
  • Nizam’s Institute of Health Sciences, Hyderabad.
  • Apollo Hospital, Hyderabad.
  • Baba Farid University of Health Sciences, Faridkot, Punjab.
  • PGIMER, Chandigarh.
Service Activity :
Provided molecular diagnostic services to all the referral cases (Total=2000) with following conditions, using HPLC, PCR, ARMS-PCR, Multiplex PCR, Reverse Dot Blot, RFLP and Sequencing:
  • Thalassemia
  • Sickle cell anemia
  • Other structural variants of hemoglobin like E and D thal.
  • Duchene Muscular Dystrophy
  • Stroke
  • Progeria
  • Neural Tube Defects
COMMUNITY SERVICE:
Health Camps
  • Participated in the Thalassemia screening camp at Rangapur village, organized by Institute of Genetics and Hospital for Genetic Diseases, O U on 4.12.2008.
  • Participated in a free health camp for women organized by Institute of Genetics and Hospital for Genetic Diseases, O U at the Institute Premises on 8.3.2010.
  • Participated in the health camp organized at AP State home for Women and Children to screen women and children for general health conditions on 8.3.2010.
  • Participated in the health camp organized at Rangapur for Zilla Parishad School children on 18.09.2010.